SNNA

Sienna Biopharmaceuticals (SNNA)

Sienna Biopharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNNA

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/02/08	01 : 32	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2020/02/06	00 : 47	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2020/01/09	22 : 00	PR Newswire (US)	Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/17	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/12	06 : 46	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/12	06 : 40	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/12	06 : 36	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/12	06 : 29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/12	06 : 23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/12/11	20 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/11/15	23 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/11/15	06 : 05	GlobeNewswire Inc.	Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/11/14	22 : 30	GlobeNewswire Inc.	Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/11/13	06 : 42	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/10/17	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/10/07	21 : 30	GlobeNewswire Inc.	Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L...	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/10/05	03 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/09/23	22 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/09/17	21 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/09/17	21 : 30	GlobeNewswire Inc.	Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/15	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/09	05 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/09	05 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/09	05 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/09	05 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/09	05 : 19	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/08/05	22 : 05	GlobeNewswire Inc.	Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/07/04	02 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/07/04	02 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc
2019/07/04	02 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNNA	Sienna Biopharmaceuticals Inc